India, Nov. 2 -- Correction: Corrected an error in the stock quote of IDXX.
Healthcare stocks moved higher following positive corporate developments and quarterly earnings reports. INOVIO Pharmaceuticals surged after receiving FDA accelerated approval for its investigational DNA-based therapy VOCERYQ, while IDEXX Laboratories and Tempus AI advanced following third-quarter financial results and updated full-year guidance.
Read on.....INOVIO Pharmaceuticals, Inc. (INO)
Shares of INOVIO surged 245% after the U.S. FDA granted accelerated approval to VOCERYQ (formerly INO-3107), a DNA-based immunotherapy designed to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP). In the Phase 1/2 RRP-001 study, 7 of ...